Creation of mortality risk charts using (123)I meta-iodobenzylguanidine heart-to-mediastinum ratio in patients with heart failure: 2- and 5-year risk models

AIMS: (123)I meta-iodobenzylguanidine (MIBG) imaging has been extensively used for prognostication in patients with chronic heart failure (CHF). The purpose of this study was to create mortality risk charts for short-term (2 years) and long-term (5 years) prediction of cardiac mortality. METHODS AND...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakajima, Kenichi, Nakata, Tomoaki, Matsuo, Shinro, Jacobson, Arnold F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5031228/
https://www.ncbi.nlm.nih.gov/pubmed/26705487
http://dx.doi.org/10.1093/ehjci/jev322

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5031228/
https://www.ncbi.nlm.nih.gov/pubmed/26705487
http://dx.doi.org/10.1093/ehjci/jev322

Ejemplares similares